SUSTAINED-RELEASE ORAL MOLSIDOMINE COMPOSITION FOR TREATING ATHEROSCLEROSIS
申请公布号:WO2005107761(A1)
申请号:WO2005EP03531
申请日期:2005.04.01
申请公布日期:2005.11.17
发明人:GECZY, JOZSEF-MICHEL
分类号:A61K9/20;A61K31/5377;(IPC1-7):A61K31/537;A61P9/10
主分类号:A61K9/20
摘要:<p>The present invention is applicable in the pharmaceutical industry and relates to the use of molsidomine or a pharmaceutically acceptable salt thereof, particularly in the form of a sustained-release solid oral composition effective for 24 hours, for producing a drug for preventing or controlling atherosclerosis.</p>
CNS PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
Method of producing floor panels
Method for producing a radiator plate, plate radiator body and distancer
DEVICE FOR PRESSURE TESTING OF PIPES
Selective sintering of structurally modified polymers
IMAGE PROCESSING DEVICE AND METHOD, DRIVING SUPPORT SYSTEM, AND VEHICLE
METHOD FOR GENERATING DOWNLINK FRAME, AND METHOD FOR SEARCHING CELL
OPTIMISING PACKET SWITCHED NETWORKS
METHOD AND APPARATUS FOR SUPPORTING DATA TRANSMISSION IN A MULTI-CARRIER COMMUNICATION SYSTEM
DISPENSING DEVICE FOR FLUID SUBSTANCES
Non-aqueous electrolyte secondary battery, negative electrode material, and making method